VrillFatNoob24
Punjabi/Khalistani
- Joined
- Feb 23, 2025
- Posts
- 672
- Reputation
- 509
ULTIMATE DHT MAXXING GUIDE
\Advanced androgenic remodeling for facial structure bone density and frame enhancement
\Advanced androgenic remodeling for facial structure bone density and frame enhancement
Dihydrotestosterone DHTis the most potent endogenous androgen it binds the androgen receptor AR with higher affinity than testosterone and cannot be aromatized to estrogen DHT governs permanent androgenic effects such as craniofacial growth jaw definition temporal thickening clavicle elongation and increased bone mineralization it plays a key role in pubertal masculinization and periosteal expansion maximizing DHT is critical for enhancing bone density frame proportions and overall aesthetics
bone remodeling dht binds to AR on periosteal cells upregulting osteogenic genes like COL1A1 RANKL and OPG and suuchhh results in periosteal apposition increased cortical thickness and BMD Srd5a1 KO , mice show impaired bone density despite normal testosterone indicating DHTs unique role it increases periosteal apposition in humans, so dht acts on the zygomatic maxillary mandibular and frontal bones via periosteal AR signaling early pubertal dht surges define forward growth depth and projection transdermal application localized to madibular angles shows remodeling over months with enhanced definition muscle and fat repartitioning also dht upregulates AR in type IIb fibers enhancing contractile density inhibits adipogenesis via PPAR gamma downregulation lipolytic in subcutaneous adipose especially around lower face and trunk clavicle and frame width AR expression in deltoid insertions and periosteum allows dHt to stimulate lateral growth paired with axial loading and GH pulses yields max biacromial gains neurobehavioral modulation DHT linked to increased visuospatial dominance lower anxiety via GABA A modulation higher levels correlate with assertiveness and social drive
transdermal DHT cream 2 to 10 mg daily apply directly to target areas zygmatic arch lower mandible temporal clavicle rotate sites to avoid dermal fibrosis
mestanolone oral dht derivative 10 to 30 m¹g per day high AR selectivity no estrogenic activity use with liver protection compounds dke to 17aa structure
drostanolone propionate injectable dth based compound 200 to 400 mg weekly divided 2x hardening and density effect especially when lean
proviron mesterolone oral weak anabolic potent AR binder 25 to 100 mg daily lowers SHBG improves free T and Dht ratio it akso enhances mood and sharpness
some considerations avoid concurrent high dose testosterone which competes for AR binding combine with GH 0.5 to 1.5 IU and insulin 1 IU post workout for anabolic synergy
cycle structure 8 to 12 weeks on 4 to 6 weeks off monitor with CBCT for bone structure DEXA for bone density labs for PSA LFTs hematocrit ideal DHT to E2 ratio is over 10
risks ts may worsen androgenic alopecia in predisposed individuals check PSA regularly elevated hematocrit manageable by phlebotomy
where to apply zygoma mandible inferior orbital rim frontal process mastoid clavicular edge scapular spine
DHT ON HAIR
dht isnt the root cause but us a downstream factor hair loss is genetically programed follicle miniaturization happens even with low dht if genes say so many men with high dht keep full hair many with low dht go bald AR density expression sensitivity and local inflammation matter more blocking dht just slows clock doesn’t rewrite it mpb is encoded not induced it’s follicular fate not hormonal assault enjoy chasing 5ar ghosts bro
zinc magnesium boron vitamin D saturated fats egg yolks red meat low PUFA intake UV expsure quality sleep low stress resistance training and avoidance of phytoestrogens plastics and environmental endocrine disruptors muh muh
\\REFERENCES\
Bhasin A et al 2001\ advanced DHT anabolic study
Shahidi N 2001 dihydrotestosterone tissue response
Windahl SH et al 2011 5 alpha reductase knockout bone mass
Park J et al 2019\ transdermal DHT effects in older men
Isaksson T 1988 GH connective tissue synthesis
Finkelstein JS 2013 T and E2 in bone maintenance
Nature 2022 periosteal AR signaling
Periosteal bone formation DHT 1996
PMC 2019 androgen receptor bone health
Testosterone volumetric BMD 2017\
Bhasin A et al 2001\ advanced DHT anabolic study
Shahidi N 2001 dihydrotestosterone tissue response
Windahl SH et al 2011 5 alpha reductase knockout bone mass
Park J et al 2019\ transdermal DHT effects in older men
Isaksson T 1988 GH connective tissue synthesis
Finkelstein JS 2013 T and E2 in bone maintenance
Nature 2022 periosteal AR signaling
Periosteal bone formation DHT 1996
PMC 2019 androgen receptor bone health
Testosterone volumetric BMD 2017\
